1. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024 Breast Cancer Therapeutics Market to surpass $28Bn by 2024: Global Market Insights Inc.

2. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  U.S. breast cancer therapeutics market accounted for largest business share in 2016 and is anticipated to grow substantially over the forecast period. Increases access to breast cancer screening, diagnosis and treatment services will be the chief growth rendering factor. Moreover, increasing adoption of therapy drug by patients will fuel regional business growth.  Rising incidence of disease due to increasing exposure to factors such as use of hormone replacement therapy (HRT), lifestyle related factors such as alcohol consumption, obesity and alteration in family size which stimulates the usage rate of therapeutics over the forecast period will propel the industry growth.  China should witness considerable growth in the coming years due to increase in awareness programs to spread alertness regarding breast cancer screening, robust economic growth and rising disposable income. Key Insights from Breast Cancer Therapeutics Market :

3. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Brazil breast cancer therapeutics market is projected to grow at a significant CAGR over the forecast period. Increased life expectancy among individuals and healthcare facility development are the chief features driving breast cancer therapeutics market growth in the country.  Some of the companies operating in breast cancer therapeutics market are Roche Diagnostics, Pfizer, AstraZeneca, Novartis, Sanofi, Eisai, and Eli Lily. New product launches, strong product pipeline, geographical expansion, mergers and acquisition will mainly boost the business. Chief industry players will endeavor to strengthen their place in this competitive market by implementation these strategies. Continued...

4. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com U.S. Breast Cancer Therapeutics Market, By Product, 2013 - 2024 (USD Billion)

5. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Bioreactor Market @ https://goo.gl/1aWif9 https://goo.gl/1aWif9 Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/466

6. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Application Trends Retail pharmacies held the largest market share in 2016 and will continue to be the biggest distribution channel for the industry over the forecast period. Growing shift from specialty to retail pharmacies owing to reimbursement variations and prolonged usage of oral formulations, particularly for targeted drug therapies will drive the business growth. Regional Trends U.S. breast cancer therapeutics market accounted for the highest regional share in 2016 due to growing prevalence of breast cancer and increasing R&D funding through public and private sectors. Growing elderly population, breast feeding discontinuation at an early stage and increased access to cancer care will stimulate industry growth. Moreover, rising demand for tumor therapeutics will strongly drive industry growth in the country. Competitive Market Share Some of the major players in global breast cancer therapeutics market are AstraZeneca, Roche Diagnostics, Pfizer, Novartis, Eisai, Eli Lilly, Sanofi, and Celgene. Roche holds the largest market share owing to wide geographical presence and strong product portfolio. It is expected to dominate the industry revenue over the coming years. The company should face intense competition from other players such as AstraZeneca and Pfizer over the forecast years. 360° Analysis

7. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media: